Type
Basic
- Chaudhary N, Choudhary BS, Shivashankar A, Manna S, Ved K, Shaikh S, Khanna S, Baar J, Dani J, Sahoo S, Soundharya R, Jolly MK, Verma N. EGFR-to-Src family tyrosine kinase switching in proliferating-DTP TNBC cells creates a hyperphosphorylation-dependent vulnerability to EGFR TKI. Cancer Cell International. 25(1):55. PMID: 39972345.
- Gaikwad P, Bargir UA, Jodhawat N, Dalvi A, Shinde S, Tamhankar P, Setia P, Kambli P, Dhawale A, Temkar L, Vedpathak D, Jose A, Gupta M, Yadav-Malik R, Dutta S, Bose K, Taur P, Gowri V, Iyengar V, Chougule A, Desai M, Sivasankaran M, Bhattad S, Balaji S, Mudaliar S, Kacha A, Subramanian G, Patel S, Sharma S, Sampagar A, Madkaikar M. Mutational Landscape of Patients with Wiskott Aldrich Syndrome: Update from India. Journal of Clinical Immunology. 45(1):56. PMID: 39688652.
- Keshari R, Bagale R, Rath S, De A, Banerjee R, Sen S, Srivastava R (2025). Transcutaneous delivery of disease-specific PI3K/Akt/mTOR inhibitor-based hybrid nanoparticles in hydrogel system for the management of psoriasis: Insights from in vivo studies. International Journal of Pharmaceutics.
- Keith B, Welch DR, Agarwal N, Blair C, Chukwudozie IB, Shevde LA, Boise LH, Burnstein KL, Antalis TM, O'Connor KL, Dalal SN, Ellis S, Nakshatri H. Challenges and opportunities in training cancer researchers. Nature Cancer. PMID: 39747649
- Kumar S, Dey P, Pathak AK, Wadawale A, Maurya DK, Natu K, Bose K, Goswami D (2025). Structure-activity relationship of ciprofloxacin towards S-Spike Protein of SARS-CoV-2: Synthesis and In-silico evaluation. Journal of Chemical Information and Modeling. 65(2):825-844. PMID: 39800972
- Lonare A, Raychaudhuri K, Shah S, Madhu G, Sachdeva A, Basu S, Thorat R, Gupta S, Dalal SN (2025). 14-3-3σ restricts YY1 to the cytoplasm, promoting therapy resistance, and tumor progression in colorectal cancer. International Journal of Cancer.156(3):623-637.PMID: 39239852
- Mahaddalkar T, Banerjee A, Ketkar M, Thorat R, Gardi N, Dutt S (2025). Aurora Kinase A and B inhibition abrogates 'Neosis', a non-mitotic cell division of GBM residual cells and prevents GBM recurrence. Oncogene.
- Oak S, Karajgikar O, Gadewal N, Sulkshane P, Verma T, Gupta S, Teni T (2025). The deubiquitinase inhibitor WP1130 drives nuclear aggregation and reactivation of mutant p53 for selective cancer cell targeting. FEBS Journal.
- Sundararajan R, Hegde SR, Panda AK, Christie J, Gadewal N, Venkatraman P. Loss of correlated proteasomal subunit expression selectively promotes the 20SHigh state which underlies luminal breast tumorigenicity. Communications Biology. 8(1): 55.PMID: 39814910
Select Year
order
-10